Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A multidimensional integrative medicine intervention to improve cardiovascular risk.

Edelman D, Oddone EZ, Liebowitz RS, Yancy WS Jr, Olsen MK, Jeffreys AS, Moon SD, Harris AC, Smith LL, Quillian-Wolever RE, Gaudet TW.

J Gen Intern Med. 2006 Jul;21(7):728-34.

2.

Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.

Vale MJ, Jelinek MV, Best JD, Dart AM, Grigg LE, Hare DL, Ho BP, Newman RW, McNeil JJ; COACH Study Group.

Arch Intern Med. 2003 Dec 8-22;163(22):2775-83.

PMID:
14662633
3.
4.

Secondary prevention risk interventions via telemedicine and tailored patient education (SPRITE): a randomized trial to improve postmyocardial infarction management.

Shah BR, Adams M, Peterson ED, Powers B, Oddone EZ, Royal K, McCant F, Grambow SC, Lindquist J, Bosworth HB.

Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):235-42. doi: 10.1161/CIRCOUTCOMES.110.951160.

5.

[Cardiovascular risk reduction: impact of an international project].

Colle B, Brusaferro S; Euroaction Steering Group.

Ann Ig. 2008 May-Jun;20(3 Suppl 1):43-8. Italian.

PMID:
18773604
6.

From concept to application: the impact of a community-wide intervention to improve the delivery of preventive services to children.

Margolis PA, Stevens R, Bordley WC, Stuart J, Harlan C, Keyes-Elstein L, Wisseh S.

Pediatrics. 2001 Sep;108(3):E42.

PMID:
11533360
7.

Reduction in cardiovascular risk using proactive multifactorial intervention versus usual care in younger (< 65 years) and older (≥ 65 years) patients in the CRUCIAL trial.

Kim JH, Zamorano J, Erdine S, Pavia A, Al-Khadra A, Sutradhar S, Yunis C; CRUCIAL Investigators.

Curr Med Res Opin. 2013 May;29(5):453-63. doi: 10.1185/03007995.2013.781503. Epub 2013 Apr 3.

PMID:
23448581
8.

Changes in calculated coronary heart disease risk using proactive multifactorial intervention versus continued usual care in Latin-American and non-Latin-American patients enrolled in the CRUCIAL trial.

Pavia A, Zamorano J, Sutradhar S, Yunis C; CRUCIAL Investigators.

Curr Med Res Opin. 2012 Oct;28(10):1667-76. doi: 10.1185/03007995.2012.725391. Epub 2012 Sep 19.

PMID:
22991979
9.

Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease.

Müller-Riemenschneider F, Damm K, Meinhard C, Bockelbrink A, Vauth C, Willich SN, Greiner W.

GMS Health Technol Assess. 2009 Dec 14;5:Doc16. doi: 10.3205/hta000078.

10.

Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial.

Shaten BJ, Kuller LH, Kjelsberg MO, Stamler J, Ockene JK, Cutler JA, Cohen JD.

Ann Epidemiol. 1997 Feb;7(2):125-36.

PMID:
9099400
11.

A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile.

Benner JS, Erhardt L, Flammer M, Moller RA, Rajicic N, Changela K, Yunis C, Cherry SB, Gaciong Z, Johnson ES, Sturkenboom MC, García-Puig J, Girerd X; REACH OUT Investigators.

Int J Clin Pract. 2008 Oct;62(10):1484-98. doi: 10.1111/j.1742-1241.2008.01872.x. Epub 2008 Aug 7.

12.

One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk.

Wister A, Loewen N, Kennedy-Symonds H, McGowan B, McCoy B, Singer J.

CMAJ. 2007 Oct 9;177(8):859-65.

13.

Exercise effects on bone mineral density, falls, coronary risk factors, and health care costs in older women: the randomized controlled senior fitness and prevention (SEFIP) study.

Kemmler W, von Stengel S, Engelke K, Häberle L, Kalender WA.

Arch Intern Med. 2010 Jan 25;170(2):179-85. doi: 10.1001/archinternmed.2009.499.

PMID:
20101013
14.

Modifiable disease risk, readiness to change, and psychosocial functioning improve with integrative medicine immersion model.

Wolever RQ, Webber DM, Meunier JP, Greeson JM, Lausier ER, Gaudet TW.

Altern Ther Health Med. 2011 Jul-Aug;17(4):38-47.

15.

Effects of exercise training on coronary heart disease risk factors in renal transplant recipients.

Painter PL, Hector L, Ray K, Lynes L, Paul SM, Dodd M, Tomlanovich SL, Ascher NL.

Am J Kidney Dis. 2003 Aug;42(2):362-9.

PMID:
12900820
16.

Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease.

Becker DM, Yanek LR, Johnson WR Jr, Garrett D, Moy TF, Reynolds SS, Blumenthal RS, Vaidya D, Becker LC.

Circulation. 2005 Mar 15;111(10):1298-304.

17.

Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study.

Lindholm LH, Ekbom T, Dash C, Isacsson A, Scherstén B.

J Intern Med. 1996 Jul;240(1):13-22.

PMID:
8708586
18.

Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England: healthcare system and patient perspectives.

Scott A, Tinelli M, Bond C; Community Pharmacy Medicines Management Evaluation Team.

Pharmacoeconomics. 2007;25(5):397-411.

PMID:
17488138
19.

Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients.

Neto PR, Marusic S, de Lyra Júnior DP, Pilger D, Cruciol-Souza JM, Gaeti WP, Cuman RK.

J Pharm Pharm Sci. 2011;14(2):249-63.

20.

A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).

McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT; SCRIP-HTN Investigators.

Arch Intern Med. 2008 Nov 24;168(21):2355-61. doi: 10.1001/archinte.168.21.2355.

PMID:
19029501

Supplemental Content

Support Center